Breast Cancer Perspective

• 5 Things to Know About Chronotherapy With the 2017 Nobel Prize in Medicine being awarded to research on circadian rhythms, the time has come to take a look at synchronizing chemotherapy with the body's natural clock. Here are five things you should know about chronotherapy.
  Medscape Oncology, August 2018
• Can We Put the 'IVF-Cancer Connection' to Bed?   A large study provides some—but not total—reassurance to women considering assisted reproduction.
  Medscape Internal Medicine, August 2018
• Should Every Metastatic Breast Cancer Patient Undergo NGS? Experts debate the advantages and disadvantages of next-generation genomic sequencing in patients with metastatic breast cancer.
  Medscape Oncology, July 2018
• Theranos Lied, but These Blood Assays Are Revolutionary If the deception of Theranos has you disappointed with biotechnological advancements, here are 10 blood test startups to restore your faith in medical innovation.
  Medscape Pathology, July 2018
• What Is the Best Approach to Managing 'Chemobrain'? Experts discuss the poorly understood but common experience of 'chemobrain' in cancer patients, including the evidence behind interventions to reduce the symptoms.
  Medscape Oncology, July 2018
• Hungry for Health: Fasting's Medical Benefits Once regarded as a fringe intervention, researchers are presenting an increasingly compelling case for the clinical value of intermittent fasting.
  Medscape Gastroenterology, July 2018
• Yet Another Cancer Screening Recommendation. This Time: Colon   The American Cancer Society now suggests beginning screening for colorectal cancer at age 45. Is that a good idea?
  Georgetown University Family Medicine, July 2018
• Hysterectomy for Benign Conditions: Remove the Ovaries? The pros and cons of hysterectomy with bilateral salpingo-oophorectomy are summarized in a recent review.
  Medscape Ob/Gyn, July 2018
• 'We've Scared Women': The Growth of Prophylactic Mastectomy Why is it that women with cancer in one breast are increasingly likely to opt for contralateral prophylactic mastectomy, when the evidence shows no survival benefit?
  Medscape Oncology, July 2018
• Metastatic Breast Cancer Center of Excellence | Medscape Metastatic Breast Cancer Center of Excellence includes the latest research, journal articles, cases, quizzes, and peer discussions of the challenges of treating metastatic breast cancer.
  June 2018
• Clinical Pathways: Many Potential Benefits but 'More Work to Do'   Drs Miller and Zon discuss the current challenges associated with clinical pathways in oncology.
  Medscape Oncology, June 2018
• Top News From ASCO 2018: Slideshow Highlights include practice-changing data in advanced non-small cell lung cancer, early breast cancer, and kidney cancer, plus welcome news of $10 million in new funding for research.
  Medscape News Slideshows, June 2018
• At ASCO, Noninferiority Trials Dominate, Prove 'Less Can Be More' Three of the biggest trials at the 2018 annual meeting of the American Society of Clinical Oncology involved reducing therapy while maintaining efficacy.
  Medscape Oncology, June 2018
• TAILORx Provides 'Clear Answer' for ER+ Breast Cancer   Lead investigator Joseph Sparano discusses the pivotal TAILORx trial presented at ASCO 2018. It's a 'great day for patients,' says Kathy Miller.
  Medscape Oncology, June 2018
• We Can't Find Lung Cancer if We Don't Look for It   Use of low-dose CT lags far behind use of other cancer screening tests.
  Medscape Internal Medicine, June 2018
• Dealing With Data Overload in Oncology   From pharmaceutical press releases to highly motivated online patient groups, oncologists are on the receiving end of a firehose of information. Here are some solutions.
  Medscape Oncology, May 2018
• Long-Awaited TAILORx Results 'Will Impact Your Practice'   'Do not miss' the results of TAILORx this year at ASCO 2018, says Dr Kathy Miller, because they will likely affect management of ER-positive breast cancer.
  Medscape Oncology, May 2018
• Calling Out the FDA's 'We Don't Regulate Medicine' Mantra Dr Vinay Prasad calls the FDA to task over the differing standards the agency uses to grant drug approvals and expanded indications.
  Medscape Oncology, May 2018
• Hormone Therapy and Risk for Cancer in BRCA1 Mutation Carriers   Dr Andrew Kaunitz discusses the impact of hormone therapy on risk for breast cancer in BRCA carriers undergoing risk-reduction surgery.
  Medscape Ob/Gyn, May 2018
• Cardio-oncology Not Just for Subspecialists   Dr Walton-Shirley leads a discussion with Drs Barac and Mehta on what cardio-oncology encompasses today and why many specialties even primary care should take note.
  theheart.org on Medscape, May 2018